Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation

Mesenchymal stromal cells (MSC) are tested in clinical trials to treat graft versus host disease (GvHD) after stem cell transplantation (SCT). In vitro studies demonstrated MSC's broad immunosuppressive activity. As infections represent a major risk after SCT, it is important to understand the...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Lucchini, Giovanna, Dander, Erica, Pavan, Fabio, Di Ceglie, Irene, Balduzzi, Adriana, Perseghin, Paolo, Gaipa, Giuseppe, Algarotti, Alessandra, Introna, Martino, Rambaldi, Alessandro, Rovelli, Attilio, Biondi, Andrea, Biagi, Ettore, D'Amico, Giovanna
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi Publishing Corporation 2012
Fag:
Clinical Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3369546/
https://ncbi.nlm.nih.gov/pubmed/22701127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/690236
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker